These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8053490

  • 1. Bcl-2 expression in human melanocytes and melanocytic tumors.
    van den Oord JJ, Vandeghinste N, De Ley M, De Wolf-Peeters C.
    Am J Pathol; 1994 Aug; 145(2):294-300. PubMed ID: 8053490
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
    Tron VA, Krajewski S, Klein-Parker H, Li G, Ho VC, Reed JC.
    Am J Pathol; 1995 Mar; 146(3):643-50. PubMed ID: 7534042
    [Abstract] [Full Text] [Related]

  • 3. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture.
    Plettenberg A, Ballaun C, Pammer J, Mildner M, Strunk D, Weninger W, Tschachler E.
    Am J Pathol; 1995 Mar; 146(3):651-9. PubMed ID: 7887447
    [Abstract] [Full Text] [Related]

  • 4. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT, van Belle P, Elenitsas R, Elder DE.
    Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
    [Abstract] [Full Text] [Related]

  • 5. bcl-2 protein expression in melanocytic neoplasms of the skin.
    Ramsay JA, From L, Kahn HJ.
    Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
    Lincoln DT, Sinowatz F, Kölle S, Takahashi H, Parsons P, Waters M.
    Anticancer Res; 1999 Feb; 19(3A):1919-31. PubMed ID: 10470136
    [Abstract] [Full Text] [Related]

  • 7. Oestrogen receptor-beta expression in melanocytic lesions.
    Schmidt AN, Nanney LB, Boyd AS, King LE, Ellis DL.
    Exp Dermatol; 2006 Dec; 15(12):971-80. PubMed ID: 17083364
    [Abstract] [Full Text] [Related]

  • 8. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

  • 9. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM, Prieto VG, Elder DE, Duncan LM.
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [Abstract] [Full Text] [Related]

  • 10. Expression of neurotrophins and their receptors in pigment cell lesions of the skin.
    Innominato PF, Libbrecht L, van den Oord JJ.
    J Pathol; 2001 May; 194(1):95-100. PubMed ID: 11329147
    [Abstract] [Full Text] [Related]

  • 11. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A, McNutt NS.
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [Abstract] [Full Text] [Related]

  • 12. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
    Kaleem Z, Lind AC, Humphrey PA, Sueper RH, Swanson PE, Ritter JH, Wick MR.
    Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A.
    Cancer; 2002 Nov 01; 95(9):1963-70. PubMed ID: 12404291
    [Abstract] [Full Text] [Related]

  • 14. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L, KEFELI M, AYDIN O, KANDEMIR B.
    Eur J Dermatol; 2009 Nov 01; 19(5):445-50. PubMed ID: 19527987
    [Abstract] [Full Text] [Related]

  • 15. Expression of the ets-1 proto-oncogene in melanocytic lesions.
    Keehn CA, Smoller BR, Morgan MB.
    Mod Pathol; 2003 Aug 01; 16(8):772-7. PubMed ID: 12920221
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
    Nambiar S, Mirmohammadsadegh A, Hassan M, Mota R, Marini A, Alaoui A, Tannapfel A, Hegemann JH, Hengge UR.
    Carcinogenesis; 2007 Dec 01; 28(12):2501-10. PubMed ID: 17768177
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
    Giehl KA, Nägele U, Volkenandt M, Berking C.
    J Cutan Pathol; 2007 Jan 01; 34(1):7-14. PubMed ID: 17214848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.